PARP2 and posterior cortical atrophy: Li’s group blocked the interaction between PARP-2 and FOXA1 by targeting PARP-2 with the selective PARP-2 inhibitor UPF-1069, thereby attenuating AR-mediated gene expression and inhibiting AR-positive PCa growth [149].